Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study
DRKS00004559Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of quetiapine and haloperidol in schizophrenia (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Motivation, Hedonia and 1 more. Started Nov 2012; status: completed.
02
Drugs
quetiapinehaloperidol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on DRKS00004559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004559.